NHNora Hünemohr

Nora Hünemohr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nora Hünemohr has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Steffen Greilich

    Division of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany

    4 shared publications
  • Oliver Jäkel

    Medical Physics in Radiation Oncology, German Cancer Research Center, 69120 Heidelberg, Germany and Department of Radiation Oncology and Radiation Therapy, University Hospital of Heidelberg, 69120 Heidelberg, Germany

    3 shared publications
  • Benjamin Ackermann

    Heidelberg Ion-Beam Therapy Center, D-69120 Heidelberg, Germany

    2 shared publications
  • Bernhard Krauss

    Imaging and Therapy Division, Siemens AG, D-91301 Forchheim, Germany

    2 shared publications
  • Armin Michael Nagel

    Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Germany (A.M.N.).

    1 shared publication
  • Christoph Tremmel

    Division of Medical Physics in Radiation Oncology, German Cancer Research Center, D-69120 Heidelberg, Germany

    1 shared publication

Latest Publications

  • Tissue decomposition from dual energy CT data for MC based dose calculation in particle therapy

    by Nora Hünemohr, Harald Paganetti, Steffen Greilich, Oliver Jäkel, Joao Seco

    The authors describe a novel method of predicting mass density and elemental mass fractions of tissues from dual energy CT (DECT) data for Monte Carlo (MC) based dose planning. The relative electron density ϱ(e) and effective atomic number Z(eff) are calculated for 71 tabulated tissue compositions. For MC simulations, the mass density is derived via one linear fit in the ϱ(e) that covers the entire range of tissue compositions (except lung tissue). Elemental mass fractions are predicted from the ϱ(e) and the Z(eff) in combination. Since particle therapy dose planning and verification is especially sensitive to accurate material assignment, differences to the ground truth are further analyzed for mass density, I-value predictions, and stopping power ratios (SPR) for ions. Dose studies with monoenergetic proton and carbon ions in 12 tissues which showed the largest differences of single energy CT (SECT) to DECT are presented with respect to range uncertainties. The standard approach (SECT) and the new DECT approach are compared to reference Bragg peak positions. Mean deviations to ground truth in mass density predictions could be reduced for soft tissue from (0.5±0.6)% (SECT) to (0.2±0.2)% with the DECT method. Maximum SPR deviations could be reduced significantly for soft tissue from 3.1% (SECT) to 0.7% (DECT) and for bone tissue from 0.8% to 0.1%. Mean I-value deviations could be reduced for soft tissue from (1.1±1.4%, SECT) to (0.4±0.3%) with the presented method. Predictions of elemental composition were improved for every element. Mean and maximum deviations from ground truth of all elemental mass fractions could be reduced by at least a half with DECT compared to SECT (except soft tissue hydrogen and nitrogen where the reduction was slightly smaller). The carbon and oxygen mass fraction predictions profit especially from the DECT information. Dose studies showed that most of the 12 selected tissues would profit significantly (up to 2.2%) from DECT material decomposition with no noise present. The ϱ(e) associated with an absolute noise of ±0.01 and Z(eff) associated with an absolute noise of ±0.2 resulted in ±10% standard variation in the carbon and oxygen mass fraction prediction. Accurate stopping power prediction is mainly determined by the correct mass density prediction. Theoretical improvements in range predictions with DECT data in the order of 0.1%-2.1% were observed. Further work is needed to quantify the potential improvements from DECT compared to SECT in measured image data associated with artifacts and noise.


  • Top Cited Papers

    Experimental verification of ion stopping power prediction from dual energy CT data in tissue surrogates

    by Nora Hünemohr, Bernhard Krauss, Christoph Tremmel, Benjamin Ackermann, Oliver Jäkel, Steffen Greilich

    We present an experimental verification of stopping-power-ratio (SPR) prediction from dual energy CT (DECT) with potential use for dose planning in proton and ion therapy. The approach is based on DECT images converted to electron density relative to water ϱe/ϱe, w and effective atomic number Zeff. To establish a parameterization of the I-value by Zeff, 71 tabulated tissue compositions were used. For the experimental assessment of the method we scanned 20 materials (tissue surrogates, polymers, aluminum, titanium) at 80/140Sn kVp and 100/140Sn kVp (Sn: additional tin filtration) and computed the ϱe/ϱe, w and Zeff with a purely image based algorithm. Thereby, we found that ϱe/ϱe, w (Zeff) could be determined with an accuracy of 0.4% (1.7%) for the tissue surrogates with known elemental compositions. SPRs were predicted from DECT images for all 20 materials using the presented approach and were compared to measured water-equivalent path lengths (closely related to SPR). For the tissue surrogates the presented DECT approach was found to predict the experimental values within 0.6%, for aluminum and titanium within an accuracy of 1.7% and 9.4% (from 16-bit reconstructed DECT images).


  • Open Access

    Ion range estimation by using dual energy computed tomography

    by Nora Hünemohr, Bernhard Krauss, Julien Dinkel, Clarissa Gillmann, Benjamin Ackermann, Oliver Jäkel, Steffen Greilich


  • Open Access

    MRI-based treatment plan simulation and adaptation for ion radiotherapy using a classification-based approach

    by Christopher M Rank, Christoph Tremmel, Nora Hünemohr, Armin M Nagel, Oliver Jäkel, Steffen Greilich

    In order to benefit from the highly conformal irradiation of tumors in ion radiotherapy, sophisticated treatment planning and simulation are required. The purpose of this study was to investigate the potential of MRI for ion radiotherapy treatment plan simulation and adaptation using a classification-based approach.